Generate:Biomedicines | WebDisclosure

Basculer en Français

10431	Companies
218649	Keywords
148146	Articles
115673	Press releases

Headlines Articles Press releases Generate:Biomedicines

Home
Companies
Generate:Biomedicines

BRIEF

published on 12/01/2025 at 12:10, 5 months 19 days ago

Generate:Biomedicines Initiates Phase 3 Trials for Asthma Antibody GB-0895

Phase 3 Trials Generate:Biomedicines GB-0895 Asthma Treatment AI Engineered Antibody
BRIEF

published on 12/01/2025 at 12:10, 5 months 19 days ago

Generate:Biomedicines lance des essais de phase 3 pour l'anticorps contre l'asthme GB-0895

Essais De Phase 3 GB-0895 Générer : Biomédicaments Traitement De L'asthme Anticorps Conçu Par IA
PRESS RELEASE

published on 12/01/2025 at 12:05, 5 months 19 days ago

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI
Generate:Biomedicines to initiate global Phase 3 studies of GB-0895, a long-acting anti-TSLP antibody for severe asthma engineered with AI. SOLAIRIA-1 and SOLAIRIA-2 will evaluate efficacy in reducing asthma exacerbations, reflecting commitment to developing innovative therapies

AI Engineering Phase 3 Studies Generate:Biomedicines GB-0895 Severe Asthma

Accesswire

Published on 05/20/2026 at 15:28, 3 hours 26 minutes ago

Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 3 hours 53 minutes ago

Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 15:00, 3 hours 54 minutes ago

BlackBerry Achieves FedRAMP Class D (High) Re-Certification as Government Demand for Mission-Critical Communications Grows
Published on 05/20/2026 at 14:00, 4 hours 54 minutes ago

Ameriwest to Advance Its Bornite Copper Project by Re-Logging and Re-Assaying Historical Drill
Published on 05/20/2026 at 14:00, 4 hours 54 minutes ago

First Canadian Graphite Reports Encouraging Results at Lac Guéret South from Airborne Survey Indicating Significant Expansion Possibilities

View all ACCESSWIRE

EQS Group

Published on 05/20/2026 at 18:30, 24 minutes ago

Orell Füssli AG: Annual General Meeting approves all proposals from the Board of Directors
Published on 05/20/2026 at 17:48, 1 hour 6 minutes ago

Commerzbank Annual General Meeting approves all agenda items
Published on 05/20/2026 at 17:46, 1 hour 7 minutes ago

Commerzbank Annual General Meeting approves all agenda items
Published on 05/20/2026 at 17:45, 1 hour 9 minutes ago

REALITES: Prorogation du délai de complétude des informations nécessaires à la conversion de créances en actions nouvelles
Published on 05/20/2026 at 17:40, 1 hour 14 minutes ago

Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.26.

Les Echos

Published on 05/20/2026 at 18:00, 54 minutes ago

General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 54 minutes ago

General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 54 minutes ago

Algemene vergadering van 20 mei 2026
Published on 05/20/2026 at 17:45, 1 hour 9 minutes ago

STEF : Droits de vote au 30-04-2026
Published on 05/20/2026 at 17:45, 1 hour 9 minutes ago

Report on share repurchases from 13 to 19 May 2026

View all LES ECHOS COMFI WIRE